Equity, SAFE or Grant: Negotiating Accelerator Terms in 2025

The accelerator term landscape in 2025 offers founders more choice than ever. Non-dilutive grant programmes (Cyberport, HKSTP) provide funding without equity dilution but lack the investor network intensity of equity-based programmes. Equity programmes (Betatron, Brinc) trade dilution for intensive mentorship and investor introductions — the ‘cost’ of the equity must be weighed against the probability that the programme meaningfully improves fundraising outcomes. SAFE programmes (Antler, certain YC-style programmes) defer the dilution question to a future priced round, which is founder-friendly in theory but can create misalignment if the accelerator has no ‘skin in the game’ in the form of priced equity. The optimal choice depends on the founder’s stage: if you are pre-product, a non-dilutive grant programme may be the least risky path; if you are post-product and pre-revenue, an equity programme that can directly connect you to seed investors may offer the highest ROI on the dilution; if you are generating revenue and can credibly raise a priced seed round within 6-12 months, a SAFE-based programme that preserves your cap table for that round may be optimal.